Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DJDawgon Aug 21, 2024 3:57pm
167 Views
Post# 36190596

RE:RE:RE:RE:RE:RE:RE:RE:POTENTIAL HOME CANCER TREATMENT

RE:RE:RE:RE:RE:RE:RE:RE:POTENTIAL HOME CANCER TREATMENTProven safe is a tricky wording. Yes. DDFW is correct has not proven safe in humans.

All data provided to date suggests that it is safe in animal models that are used as a proxy. The process involves giving the drug to animals and measuring a million parameters to see if any suggestion of "toxicity". They have been doing this for a while and so far all reports are good but it is not like they are releasing all the lab data.

A phase 1b is a test in humans where you start off with a low dose and see if any adverse reactions. Then move up the dose to a more therapeutic dose.

So the most likely / hopeful status is that in tests done so far there have not been any reported adverse reactions in animal models and the company continues to move towards phase 1b.

Also note that phase 1b is in essentially palliative GBM / NSCLC so there is a different bar compared to testing out a cholesterol drug in an otherwise healthy adult. Some adverse reactions in a palliative patient can be accepted if the tradeoff is tumour shrinkage, QAL etc, whereas the same would not apple to a cholesterol drug.

<< Previous
Bullboard Posts
Next >>